ArticlePloS one2022
Deep learning time series prediction models in surveillance data of hepatitis incidence in China.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Forecasting monthly hepatitis B cases in China: a nationwide comparative study based on surveillance data.BMC public health · 2026Article
- Enhancing infectious disease prediction model selection with multi-objective optimization: an empirical study.PeerJ. Computer science · 2024Article
- Machine Learning Approaches for the Prediction of Hepatitis B and C Seropositivity.International journal of environmental research and public health · 2023Article
- Top-Down Proteomics Detection of Potential Salivary Biomarkers for Autoimmune Liver Diseases Classification.International journal of molecular sciences · 2023Article
- Article
- Development and comparison of predictive models for sexually transmitted diseases-AIDS, gonorrhea, and syphilis in China, 2011-2021.Frontiers in public health · 2022Article
- Prediction of Liquid Magnetization Series Data in Agriculture Based on Enhanced CGAN.Frontiers in plant science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrecise incidence prediction of Hepatitis infectious disease is critical for early prevention and better government strategic planning. In this paper, we presented different prediction models using deep learning methods based on the monthly incidence of Hepatitis through a national public health surveillance system in China mainland.
methodsWe assessed and compared the performance of three deep learning methods, namely, Long Short-Term Memory (LSTM) prediction model, Recurrent Neural Network (RNN) prediction model, and Back Propagation Neural Network (BPNN) prediction model. The data collected from 2005 to 2018 were used for the training and prediction model, while the data are split via 5-Fold cross-validation. The performance was evaluated based on three metrics: mean square error (MSE), mean absolute error (MAE), and mean absolute percentage error (MAPE).
resultsAmong the year 2005-2018, 20,924,951 cases and 11,892 deaths were supervised in the system. Hepatitis B (HB) is the most disease-causing incidence and death, and the proportion is greater than 70 percent, while the percentage of the incidence and deaths is decreased much in 2018 compared with 2005. Based on the measured errors and the visualization of the three neural networks, there is no one model predicting the incidence cases that can be completely superior to other models. When predicting the number of incidence cases for HB, the performance ranking of the three models from high to low is LSTM, BPNN, RNN, while it is LSTM, RNN, BPNN for Hepatitis C (HC). while the MAE, MSE and MAPE of the LSTM model for HB, HC are 3.84*10-06, 3.08*10-11, 4.981, 8.84*10-06, 1.98*10-12,5.8519, respectively.
conclusionsThe deep learning time series predictive models show their significance to forecast the Hepatitis incidence and have the potential to assist the decision-makers in making efficient decisions for the early detection of the disease incidents, which would significantly promote Hepatitis disease control and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.